kotenka_m (kotenka_m) wrote,

Интересный комментарий по применению аспирина у пожилых пациентов

Лежит тут https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.13929?elq_mid=36797&elq_cid=3005066

"Despite this poor benefit‐to‐harm balance of aspirin, Parekh et al found that anti‐platelets agents were only 13th on a list of medications associated with medication‐related harms (MRH) following hospital discharge in 1280 older adults.5 Aspirin was behind opiates, antibiotics, benzodiazepines, diuretics and antihypertensives. The overall incidence of MRH‐associated hospital readmission was ~8% (78 per 1000 discharges), at an estimated cost to the National Health Service of £396 million annually, over 60% of which (£243 million) was considered to be potentially preventable.5

Therefore, whilst prescribers should remember the need for antiplatelets in secondary prevention, they should reconsider the use of aspirin for primary prevention and focus more on good control of the other risk factors: blood pressure and cholesterol (the latter mainly via use of statins). Perhaps the current success of these other interventions now leaves little room for benefit from aspirin in primary prevention?"

Tags: врачебное, интересное, на память
  • Post a new comment


    Anonymous comments are disabled in this journal

    default userpic

    Your reply will be screened

    Your IP address will be recorded